Welcome to LookChem.com Sign In|Join Free

CAS

  • or

114655-02-6

Post Buying Request

114655-02-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

114655-02-6 Usage

Chemical Properties

White Solid

Uses

Paclitaxel derivative as antitumor agent

Check Digit Verification of cas no

The CAS Registry Mumber 114655-02-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,6,5 and 5 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 114655-02:
(8*1)+(7*1)+(6*4)+(5*6)+(4*5)+(3*5)+(2*0)+(1*2)=106
106 % 10 = 6
So 114655-02-6 is a valid CAS Registry Number.

114655-02-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2'-O-(tert-Butyldimethylsilyl)taxol

1.2 Other means of identification

Product number -
Other names 2'-O-(2-METHOXYETHYL)-5-METHYL-URIDINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:114655-02-6 SDS

114655-02-6Relevant articles and documents

Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(ε-caprolactone) micelle nanocarriers: Pharmacokinetic disposition, tolerability, and cytotoxicity

Forrest, M. Laird,Yanez, Jaime A.,Remsberg, Connie M.,Ohgami, Yusuke,Kwon, Glen S.,Davies, Neal M.

, p. 194 - 206 (2008)

Purpose. Develop a Cremophor and solvent free formulation of paclitaxel using amphiphilic block co-polymer micelles of poly(ethylene glycol)-b-poly(ε-caprolactone) (PEG-b-PCL) and characterize their release, solubility, cytotoxicity, tolerability, and dis

Paclitaxel-functionalized gold nanoparticles

Gibson, Jacob D.,Khanal, Bishnu P.,Zubarev, Eugene R.

, p. 11653 - 11661 (2007)

Here we describe the first example of 2 nm gold nanoparticles (Au NPs) covalently functionalized with a chemotherapeutic drug, paclitaxel. The synthetic strategy involves the attachment of a flexible hexaethylene glycol linker at the C-7 position of pacli

Ferrocenyl Paclitaxel and Docetaxel Derivatives: Impact of an Organometallic Moiety on the Mode of Action of Taxanes

Wieczorek, Anna,B?au?, Andrzej,?al, Aleksandra,Arabshahi, Homayon John,Reynisson, Jóhannes,Hartinger, Christian G.,Rychlik, B?a?ej,Pla?uk, Damian

, p. 11413 - 11421 (2016)

A series of ferrocenyl analogues and derivatives of paclitaxel and docetaxel were synthesised and assayed for their antiproliferative/cytotoxic effects, impact on the cell cycle distribution and ability to induce tubulin polymerisation. The replacement of the 3′-N-benzoyl group of paclitaxel with a ferrocenoyl moiety, in particular, led to formation of an analogue that was at least one order of magnitude more potent in terms of antiproliferative activity than the parent compound (IC50values of 0.11 versus 1.11 μm, respectively), but still preserved the classical taxane mode of action, that is, microtubule stabilisation leading to mitotic arrest. Molecular docking studies revealed an unexpected binding pocket in the tubulin structure for the ferrocenoyl group introduced in the paclitaxel backbone.

Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids

Casciano, Fabio,Marchesi, Elena,Melloni, Elisabetta,Navacchia, Maria Luisa,Perrone, Daniela,Preti, Lorenzo,Rimondi, Erika,Romani, Arianna,Secchiero, Paola

, (2022/01/20)

Chenodeoxycholic acid and ursodeoxycholic acid (CDCA and UDCA, respectively) have been conjugated with paclitaxel (PTX) anticancer drugs through a high-yield condensation reaction. Bile acid-PTX hybrids (BA-PTX) have been investigated for their pro-apopto

Taxol-DHA-dextran coupling polymer, synthetic method thereof and application of polymer

-

Paragraph 0060; 0139; 0154-0156, (2019/10/01)

The invention provides a taxol-DHA-dextran coupling polymer, a synthetic method thereof and an application of the polymer, and belongs to the technical field of biological medicines. According to thepolymer, polysaccharides serve as polymer drug-loaded frameworks, so that an anti-tumor drug-polysaccharide passive targeted coupling polymer is prepared, taxol can be passively targeted into a tumortissue by the aid of an EPR effect, and an anti-tumor function is played. Water solubility and biocompatibility of taxol medicines can be increased, accumulation of anti-tumor medicines in the tumor tissue can be increased under the passive targeted action, general side effect and nervous side effect of the taxol medicines are reduced, and the polymer has good practical application values.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 114655-02-6